mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.01 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.01 |
mRNA |
sotrastaurin |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.01 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.01 |
mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.01 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.02 |
mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.02 |